Peter R. Dolan

Peter R. Dolan is the Chairman of the Board of Allied Minds plc and is the former CEO of Bristol-Myers Squibb. He joined Bristol-Myers Squibb in 1988 and held various senior management positions, including President of the company's Products Division and Mead Johnson Nutritionals and Group President of Medical Devices and Nutritionals. He became President in 2000 and Chairman of the Board and CEO in 2001.

He was fired from Bristol-Myers Squibb in 2006 because of a patent dispute over Plavix, a blood-thinning drug and a major source of the company's revenues. The dispute led to an estimated $2 billion in lost sales when a generic equivalent produced by Apotex Inc. went on the market. After leaving Bristol-Myers Squibb, he was named Chairman of the Board and CEO of Gemin X Pharmaceuticals, Inc. 

Peter R. Dolan was born in 1956 in Massachusetts. He earned a Bachelor of Arts degree form Tufts University in 1978 in Social Psychology and a Master of Business Administration from Dartmouth's Tuck School of Business in 1980. He is Chairman of the Board of Trustees of Tufts University, was elected as Chairman in November 2013 and has served as a trustee since 2001. He is also Vice Chair of the Board of Directors for the Partnership for a Healthier America.

He has served on the boards of several for-profits and nonprofits, including the American Express Company, The National Center on Addiction and Substance Abuse and the Tuck School Board of Overseers at Dartmouth College. He has also served as Chairman of the Board of Pharmaceutical Research and Manufacturers of America.